enGene Holdings Inc (NASDAQ:ENGN) has a beta value of -0.62 and has seen 2.1 million shares traded in the last trading session. The company, currently valued at $345.11M, closed the last trade at $6.77 per share which meant it lost -$0.39 on the day or -5.45% during that session. The ENGN stock price is -171.79% off its 52-week high price of $18.40 and 34.71% above the 52-week low of $4.42. If we look at the company’s 10-day average daily trading volume, we find that it stood at 69720.0 shares traded. The 3-month trading volume is 126.05K shares.
The consensus among analysts is that enGene Holdings Inc (ENGN) is Buy stock at the moment, with a recommendation rating of 1.11. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
enGene Holdings Inc (NASDAQ:ENGN) trade information
Sporting -5.45% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ENGN stock price touched $6.77 or saw a rise of 12.31%. Year-to-date, enGene Holdings Inc shares have moved 1.80%, while the 5-day performance has seen it change -5.18%. Over the past 30 days, the shares of enGene Holdings Inc (NASDAQ:ENGN) have changed 13.59%. Short interest in the company has seen 0.77 million shares shorted with days to cover at 11.39.
Wall Street analysts have a consensus price target for the stock at $17.5, which means that the shares’ value could jump 61.31% from current levels. The projected low price target is $17.0 while the price target rests at a high of $18.0. In that case, then, we find that the current price level is -165.88% off the targeted high while a plunge would see the stock gain -151.11% from current levels.
enGene Holdings Inc (ENGN) estimates and forecasts
Figures show that enGene Holdings Inc shares have underperformed across the wider relevant industry. The company’s shares have lost -24.78% over the past 6 months, with this year growth rate of -7.53%, compared to 16.40% for the industry.
Earnings growth for 2025 is a modest -9.58% while over the next 5 years, the company’s earnings are expected to decrease by -7.67%.
ENGN Dividends
enGene Holdings Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Also the top two Mutual Funds that are holding company’s shares are Franklin Strategic Series-Franklin Biotechnology Discove and Fidelity NASDAQ Composite Index Fund . As of Oct 31, 2024 , the former fund manager holds about 0.81% shares in the company for having 414.26 shares of worth $2.8 million while later fund manager owns 27.52 shares of worth $0.19 million as of Nov 30, 2024 , which makes it owner of about 0.05% of company’s outstanding stock.
